The American Society for Microbiology (ASM) has announced the launch of its new fully open access journal, ASM Case Reports, which will begin publishing case reports in 2025 and accepting submissions starting mid-2024. ASM Case Reports will be a dedicated platform for the prompt publication of high-quality case reports in clinical microbiology and infectious diseases, an extensive and rapidly growing body of research.
ASM Case Reports will explore new diseases, elaborate disease progressions, the detailed actions and effects of pharmaceuticals, and the emerging frontiers of clinical microbiology and infectious diseases. The journal will publish case reports that elucidate aspects of pathogen diagnosis, pathogen roles in diseases, and the dynamics of infectious outbreaks. Case reports will undergo rigorous review and swift publication.
ASM Case Reports will be anchored by 2 highly successful and established ASM journals, Antimicrobial Agents and Chemotherapy and Journal of Clinical Microbiology. Together with existing multidisciplinary open access titles, this new forum for important research findings will significantly broaden the ecosystem of clinically relevant research published by ASM Journals.
ASM Journals has begun their search for an Editor-in-Chief (EiC), who will begin their 5-year renewable term on July 1, 2024. The EiC will be instrumental in shaping the journal's direction, complementing ASM's existing research journals. Scientists and physicians are encouraged to apply or nominate a peer for this role as inaugural EiC. While previous editorial experience is beneficial, it is not mandatory. Nominations, including self-nominations, will be accepted until Feb. 8.
Click here to read the original press release.
